1. Home
  2. SCYX vs LFT Comparison

SCYX vs LFT Comparison

Compare SCYX & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$2.97

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo Lument Finance Trust Inc.

LFT

Lument Finance Trust Inc.

SELL

Current Price

$3.80

Market Cap

35.8M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
SCYX
LFT
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
35.8M
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
SCYX
LFT
Price
$2.97
$3.80
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $32.67
N/A
AVG Volume (30 Days)
★ 59.4K
15.3K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
★ 31.83%
EPS Growth
★ 61.36
N/A
EPS
★ N/A
N/A
Revenue
★ $257,000.00
N/A
Revenue This Year
N/A
$168.78
Revenue Next Year
$977.86
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$3.76
52 Week High
$6.09
$69.35

Technical Indicators

Market Signals
Indicator
SCYX
LFT
Relative Strength Index (RSI) 26.17 41.54
Support Level $0.66 N/A
Resistance Level $4.15 $5.83
Average True Range (ATR) 0.25 0.20
MACD -0.04 0.14
Stochastic Oscillator 4.17 2.78

Price Performance

Historical Comparison
SCYX
LFT

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About LFT Lument Finance Trust Inc.

Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.

Share on Social Networks: